Bottom line
Is GIOTX a good fund? The bottom line
GIOTX is the Class III share class of GMO International Developed Equity Allocation Fund, an actively managed allocation / balanced mutual fund from Gmo.
It charges 0.63% — about $63 a year on every $10,000 invested, cheaper than 77% of allocation / balanced funds we track.
It returned +43.7% over one year, +13.4% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $223 million in net assets and 4 holdings, its largest position is GMO International Equity Fund (70.0%) and the top 10 make up 100% of the portfolio.
What stands out
- Low cost: cheaper than 77% of allocation / balanced peers
- 5-year return beat 99% of category peers
What to watch
- Concentrated: top 10 holdings are 100% of assets
Updated Nov 19, 2026
What GIOTX invests in
Total return greater than that of its benchmark, the MSCI World ex USA Index.
The Fund is a fund of funds and invests primarily in equities traded in non-U.S. markets (including emerging markets) through its investment in Equity Funds and GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). The Fund also may invest directly in securities (including other underlying funds) and derivatives. GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Funds…
From the fund's prospectus (filed Oct 20, 2026).
GIOTX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GIOTX | +43.7% | +13.4% | +10.1% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What GIOTX costs
On a $10,000 investment, GIOTX's 0.63% expense ratio costs about $63 a year. The prospectus estimates $842 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
GIOTX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | GMO International Equity Fund | 70.04% |
| 2 | GMO International Opportunistic Value Fund | 22.68% |
| 3 | GMO-Usonian Japan Value Creation Fund | 7.22% |
| 4 | State Street Global Advisors | 0.11% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 100% of the fund. See all top 25 holdings and asset mix →